This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

The Incidence of Hyperglycemia in Patients Treated With Olanzapine

Fuminari Misawa, Shingo Miyaji, Yasuo Fujii, Ryoji Miyata, Keiko Obi, Fumio Koshiishi, Hiroyuki Shimada, Masamichi Fukuda, and Takanori Koizumi

Published: March 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Results. The mean anger/aggressiveness score of patients with MDD was 0.82, significantly higher (p < .01) compared with that of patients with anxiety (0.57) or somatoform disorders(0.58). The difference remained significant (p < .01) when multivariate analysis of variance was used to adjust for age and gender. Also, the proportion of patients with clinically relevant anger/aggressiveness (score ≥ 2) was significantly higher(p < .05) among patients with MDD (N = 48, 21.6%) than among patients with anxiety (N = 29, 12.3%) or somatoform disorders (N = 3, 11.5%). The difference remained significant(p < .01) in a multiple logistic regression model including age and gender


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 65

Quick Links: Schizophrenia and Schizoaffective Disorders , Side Effects

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...